Elisa Zaghi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation.
Journal: Frontiers in immunology
Published: July 24, 2023
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide.
Journal: Frontiers in immunology
Published: November 16, 2021
Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies.
Journal: Transplantation and cellular therapy
Published: December 25, 2020
Single-cell profiling reveals the dynamics of cytomegalovirus-specific T cells in haploidentical hematopoietic stem cell transplantation.
Journal: Haematologica
Published: November 17, 2020
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes.
Journal: Cancers
Published: October 20, 2020
Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
Journal: Frontiers in immunology
Published: July 31, 2019
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy.
Journal: Journal of leukocyte biology
Published: October 22, 2018
Ether-Oxygen Containing Electrospun Microfibrous and Sub-Microfibrous Scaffolds Based on Poly(butylene 1,4-cyclohexanedicarboxylate) for Skeletal Muscle Tissue Engineering.
Journal: International journal of molecular sciences
Published: September 28, 2018
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation.
Journal: Haematologica
Published: December 16, 2017
Last Updated: 09/26/2026